297 related articles for article (PubMed ID: 25667263)
1. Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.
Levinson KJ; De Jesus M; Mantis NJ
Infect Immun; 2015 Apr; 83(4):1674-83. PubMed ID: 25667263
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.
Levinson KJ; Baranova DE; Mantis NJ
Vaccine; 2016 Nov; 34(48):5833-5836. PubMed ID: 27773473
[TBL] [Abstract][Full Text] [Related]
3. Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility.
Charles RC; Kelly M; Tam JM; Akter A; Hossain M; Islam K; Biswas R; Kamruzzaman M; Chowdhury F; Khan AI; Leung DT; Weil A; LaRocque RC; Bhuiyan TR; Rahman A; Mayo-Smith LM; Becker RL; Vyas JM; Faherty CS; Nickerson KP; Giffen S; Ritter AS; Waldor MK; Xu P; Kováč P; Calderwood SB; Kauffman RC; Wrammert J; Qadri F; Harris JB; Ryan ET
mBio; 2020 Nov; 11(6):. PubMed ID: 33203761
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo.
Apter FM; Michetti P; Winner LS; Mack JA; Mekalanos JJ; Neutra MR
Infect Immun; 1993 Dec; 61(12):5279-85. PubMed ID: 8225601
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to outer membrane proteins of Vibrio cholerae induce protection by inhibition of intestinal colonization of vibrios.
Sengupta DK; Sengupta TK; Ghose AC
FEMS Microbiol Immunol; 1992 Jul; 4(5):261-6. PubMed ID: 1515155
[TBL] [Abstract][Full Text] [Related]
6. Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of
Kauffman RC; Adekunle O; Yu H; Cho A; Nyhoff LE; Kelly M; Harris JB; Bhuiyan TR; Qadri F; Calderwood SB; Charles RC; Ryan ET; Kong J; Wrammert J
mBio; 2021 Apr; 12(2):. PubMed ID: 33879588
[No Abstract] [Full Text] [Related]
7. Immunogenicity and protective role of an IgA reactive 31-kDa antigen of Vibrio cholerae O139.
Kumar S; Ray P; Singh H; Ganguly NK
J Med Microbiol; 2001 Jun; 50(6):489-498. PubMed ID: 11393286
[TBL] [Abstract][Full Text] [Related]
8. New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection.
Winner L; Mack J; Weltzin R; Mekalanos JJ; Kraehenbuhl JP; Neutra MR
Infect Immun; 1991 Mar; 59(3):977-82. PubMed ID: 1705246
[TBL] [Abstract][Full Text] [Related]
9. Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility.
Wang Z; Lazinski DW; Camilli A
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795359
[TBL] [Abstract][Full Text] [Related]
10. Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide.
Levinson KJ; Giffen SR; Pauly MH; Kim DH; Bohorov O; Bohorova N; Whaley KJ; Zeitlin L; Mantis NJ
J Immunol Methods; 2015 Jul; 422():111-7. PubMed ID: 25865265
[TBL] [Abstract][Full Text] [Related]
11. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional profiling of Vibrio cholerae O1 following exposure to human anti- lipopolysaccharide monoclonal antibodies.
Baranova DE; Willsey GG; Levinson KJ; Smith C; Wade J; Mantis NJ
Pathog Dis; 2020 Jun; 78(4):. PubMed ID: 32589220
[TBL] [Abstract][Full Text] [Related]
13. On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba.
Wang J; Villeneuve S; Zhang J; Lei P; Miller CE; Lafaye P; Nato F; Szu SC; Karpas A; Bystricky S; Robbins JB; Kovác P; Fournier JM; Glaudemans CP
J Biol Chem; 1998 Jan; 273(5):2777-83. PubMed ID: 9446585
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Salmonella enterica serovar typhimurium motility and entry into epithelial cells by a protective antilipopolysaccharide monoclonal immunoglobulin A antibody.
Forbes SJ; Eschmann M; Mantis NJ
Infect Immun; 2008 Sep; 76(9):4137-44. PubMed ID: 18625740
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a 20-kDa pilus protein expressed by a diarrheogenic strain of non-O1/non-O139 Vibrio cholerae.
Sengupta TK; Nandy RK; Mukhopadhyay S; Hall RH; Sathyamoorthy V; Ghose AC
FEMS Microbiol Lett; 1998 Mar; 160(2):183-9. PubMed ID: 9532736
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection of Vibrio cholerae O:1 by motility inhibition and immunofluorescence with monoclonal antibodies.
Gustafsson B; Holme T
Eur J Clin Microbiol; 1985 Jun; 4(3):291-4. PubMed ID: 2410265
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial immunity to Vibrio cholerae in rats.
Cooper GN; Narendranathan R
J Med Microbiol; 1986 Sep; 22(2):133-41. PubMed ID: 3746875
[TBL] [Abstract][Full Text] [Related]
18. Cumulative protective efficacy of rZot and rAce combination in challenge experiments with wild type Vibrio cholerae in mouse model.
Anvari S; Najar-Peerayeh S; Behmanesh M; Bakhshi B
Hum Vaccin Immunother; 2018; 14(9):2323-2328. PubMed ID: 29852089
[TBL] [Abstract][Full Text] [Related]
19. Antigens involved in resistance to mucosal association by Vibrio cholerae.
Narendranathan R; Lutze LH; Jackson GD; Cooper GN
J Med Microbiol; 1988 Feb; 25(2):129-38. PubMed ID: 3339633
[TBL] [Abstract][Full Text] [Related]
20. IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity.
Yang JS; An SJ; Jang MS; Song M; Han SH
PLoS One; 2019; 14(3):e0213507. PubMed ID: 30845262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
